Eris

ERIS.NS

Tags: IN Healthcare Drug Manufacturers - Specialty & Generic

Eris Lifesciences Limited Price (ERIS.NS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

136,168,109

(0)%

Market Cap of Eris (ERIS.NS)

Market cap:

As of , ERIS.NS has a market cap of . This makes ERIS.NS the 356th most valuable company in the IN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $815.85-1593.9
Market Cap 170.20B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Amit Indubhushan Bakshi
IPO Date: June, 30, 2017
Country: IN
Currency: INR
Headquaters: No Data
Employees: 3620

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: